Jiangsu Hengrui Medicine's camrelizumab receives first approval in China for treatment of lymphoma June 3, 2019
First phase I results for anti-GITR antibody MK-4166 in patients with advanced solid tumors June 3, 2019
Dermavant Sciences initiates phase III study of tapinarof for the treatment of plaque psoriasis June 3, 2019
RSS